The excimer laser transmyocardial revascularization system, Ramez E.N. Shehada, T. Papaioannou and Warren S. Grundfest; cardiogenesis surgical transmyocardial revascularization angina treatments - lasers and normal therapies in comparison (the ATLANTIC Trial), Daniel Burkhoff; the Eclipse Ho - YAG surgical transmyocardial laser revascularization system, Keith B. Allen and Carl J. Shaar; the heart laser CO2 surgical transmyocardial revascularization system, Stephen Boyce; percutaneous transmyocardial revascularization using radiofrequency energy, Birgit Kantor et al; mechanical myocardial channelling - a mechanical alternative to laser transmyocardial revascularization, Marvin J. Slepian; the biosense guided direct myocardial revascularization, Ran Kornowski, Shmuel Fuchs and Martin B. Leon; the biosense guided transendocardial injection system for therapeutic myocardial angiogenesis, Ran Kornowski and Martin B. Leon; percutaneous transmyocardial revascularization (PTMR) - the Eclipse system and studies, Gregg W. Stone; the cardiogenesis percutaneous myocardial revascularization system, Robert J. Whitbourn and Stephen N. Oesterle; vascular endothelial growth factor (rhVEGF) protein therapy for ischemic coronary disease, Edward R. McCluskey; vascular endothelial growth factor (VEGF) gene therapy for peripheral and coronary artery diseases, Douglas W. Losordo et al; biological revascularization using adenovirus coding for vascular endothelial growth factor 121, Leonard Y. Lee et al; basic fibroblast growth factor protein for peripheral vascular disease, Daisy F. Lazarous; basic fibroblast growth factor protein for coronary artery disease, Roger J. Laham and Michael Simons; the intrapericardial approach for therapeutic angiogenesis, Keith L. March; intramyocardial injection of acidic fibroblast growth factor - adjunct to bypass surgery and monotherapy for coronary heart disease, Thomas J. Stegmann; fibroblast growth factor-1 (FGF-1) gene therapy for ischemic arterial disease, Richard Pilsudski et al.
